Merz, M., Mai, E. K., Bertsch, U., Hose, D., Seckinger, A., Jauch, A., . . . Goldschmidt, H. (2015). Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: An interim analysis from the prospective GMMG-MM5 trial. Haematologica, 100(7), . https://doi.org/10.3324/haematol.2015.124347
Chicago-Zitierstil (17. Ausg.)Merz, Maximilian, et al. "Subcutaneous Versus Intravenous Bortezomib in Two Different Induction Therapies for Newly Diagnosed Multiple Myeloma: An Interim Analysis from the Prospective GMMG-MM5 Trial." Haematologica 100, no. 7 (2015). https://doi.org/10.3324/haematol.2015.124347.
MLA-Zitierstil (9. Ausg.)Merz, Maximilian, et al. "Subcutaneous Versus Intravenous Bortezomib in Two Different Induction Therapies for Newly Diagnosed Multiple Myeloma: An Interim Analysis from the Prospective GMMG-MM5 Trial." Haematologica, vol. 100, no. 7, 2015, https://doi.org/10.3324/haematol.2015.124347.